🇺🇸 Generic lamotrigine in United States

42 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 42

Most-reported reactions

1. Completed Suicide — 12 reports (28.57%)
2. Cardio-Respiratory Arrest — 5 reports (11.9%)
3. Maternal Drugs Affecting Foetus — 5 reports (11.9%)
4. Drug Abuse — 3 reports (7.14%)
5. Drug Reaction With Eosinophilia And Systemic Symptoms — 3 reports (7.14%)
6. Exposure Via Ingestion — 3 reports (7.14%)
7. Suicidal Ideation — 3 reports (7.14%)
8. Toxic Epidermal Necrolysis — 3 reports (7.14%)
9. Toxicity To Various Agents — 3 reports (7.14%)
10. Anxiety — 2 reports (4.76%)

Source database →

Frequently asked questions

Is Generic lamotrigine approved in United States?

Generic lamotrigine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Generic lamotrigine in United States?

University of Maryland, Baltimore is the originator. The local marketing authorisation holder may differ — check the official source linked above.